SEC Form 4 · accession 0001213900-18-014143
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Edward Kelly
Director
Period of report
Oct 12, 2018
Accepted (ET)
Oct 19, 2018 · 1:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 12, 2018 | P | 150,000 | $0.90 | A | 160,000 | D | |
| Common Stock | Oct 18, 2018 | C | 223,483 | $0.72 | A | 383,483 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $1.50 | Oct 12, 2018 | P | 97,500 | A | Oct 12, 2018 | Oct 12, 2023 | Common stock | 97,500 | 97,500 | D |